NASH: From liver diseases to metabolic disorders and back to clinical hepatology
- 1 February 2002
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 35 (2), 497-499
- https://doi.org/10.1053/jhep.2002.31551
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndromeHepatology, 2002
- The Worldwide Obesity EpidemicObesity Research, 2001
- Projection of Diabetes Burden Through 2050Diabetes Care, 2001
- Nonalcoholic Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Liver Fibrosis in the Severely ObeseGastroenterology, 2001
- Prevalence of Obesity and Diabetes in Patients With Cryptogenic Cirrhosis: A Case-Control StudyHepatology, 2000
- Liver fibrosis in overweight patientsGastroenterology, 2000
- Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.Diabetes Care, 1999
- Liver Pathology and the Metabolic Syndrome X in Severe ObesityJournal of Clinical Endocrinology & Metabolism, 1999
- Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying diseaseHepatology, 1999
- Liver Steatosis and Liver ResectionDigestion, 1969